Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cross Country Healthcare (CCRN) Invested Capital: 2009-2024

Historic Invested Capital for Cross Country Healthcare (CCRN) over the last 16 years, with FY2024 value amounting to $423.4 million.

  • Cross Country Healthcare's Invested Capital fell 481.56% to $408.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $408.1 million, marking a year-over-year decrease of 481.56%. This contributed to the annual value of $423.4 million for FY2024, which is 1076.52% down from last year.
  • Cross Country Healthcare's Invested Capital amounted to $423.4 million in FY2024, which was down 1076.52% from $474.4 million recorded in FY2023.
  • Over the past 5 years, Cross Country Healthcare's Invested Capital peaked at $474.4 million during FY2023, and registered a low of $157.3 million during FY2020.
  • Moreover, its 5-year median value for Invested Capital was $423.4 million (2024), whereas its average is $363.8 million.
  • Its Invested Capital has fluctuated over the past 5 years, first crashed by 3289.92% in 2020, then surged by 9387.29% in 2021.
  • Over the past 5 years, Cross Country Healthcare's Invested Capital (Annual) stood at $157.3 million in 2020, then skyrocketed by 93.87% to $305.0 million in 2021, then soared by 50.47% to $459.0 million in 2022, then grew by 3.37% to $474.4 million in 2023, then dropped by 10.77% to $423.4 million in 2024.
  • Its last three reported values are $423.4 million in FY2024, $474.4 million for FY2023, and $459.0 million during FY2022.